首页> 外文期刊>American Journal of Pathology >Correlation of CXCL12 Expression and FoxP3+ Cell Infiltration with Human Papillomavirus Infection and Clinicopathological Progression of Cervical Cancer
【24h】

Correlation of CXCL12 Expression and FoxP3+ Cell Infiltration with Human Papillomavirus Infection and Clinicopathological Progression of Cervical Cancer

机译:CXCL12表达和FoxP3 +细胞浸润与人乳头瘤病毒感染与宫颈癌临床病理进展的相关性

获取原文
获取原文并翻译 | 示例
           

摘要

Human cervical cancer is an immunogenic tumor with a defined pattern of histopathological and clinical progression. Tumor-infiltrating T cells contribute to immune control of this tumor; however, cervical cancer dysregulates this immune response both through its association with human papillomavirus (HPV) infection and by producing cytokines and chemokines. Animal tumor models have revealed associations between overproduction of the chemokine stromal cell-derived factor-1 (SDF-1 or CXCL12) and dysregulation of tumor-specific immunity. We therefore proposed that CXCL12 expression by cervical precancerous and cancerous lesions correlates with histopathological progression, loss of immune control of the tumor, and HPV infection. We found a significant association between cancer stage and CXCL12 expression for squamous and glandular lesions as well as with the HPV16+ (high-risk) status of the neoplastic lesions. Cancer progression was correlated with increasing levels of FoxP3 T-cell infiltration in the tumor. FoxP3 and CXCL12 expression significantly correlated for squamous and glandular neoplastic lesions. These observations were supported by enzyme-linked immunosorbent assay and Western blotting. In addition, we demonstrated CXCL12 expression by dyskaryotic cells in ThinPrep cervical smears. This study robustly links increased CXCL12 expression and FoxP3+-cell infiltration to HPV infection and progression of cervical cancer. It supports the detection of CXCL12 in cervical smears and biopsies as an additional biomarker for this disease.
机译:人宫颈癌是一种具有组织病理学和临床进展的 模式的免疫原性肿瘤。肿瘤浸润 T细胞有助于对该肿瘤的免疫控制。但是, 宫颈癌通过与人乳头瘤病毒(HPV)感染相关的 以及通过产生细胞因子和趋化因子而 来异常调节这种免疫应答。动物肿瘤模型揭示了趋化因子 基质细胞衍生因子1(SDF-1或CXCL12)的过度生产与肿瘤的调节异常 之间的关联。特异性免疫。因此,我们认为宫颈癌前病变和癌性病变中CXCL12 的表达与组织病理学进展, 肿瘤的免疫控制丧失和HPV感染相关。我们发现鳞状和 腺癌的癌症分期与CXCL12表达之间的显着关联 与HPV16 +(高危)状态的 肿瘤性病变。癌症进展与肿瘤中FoxP3 T细胞浸润水平的升高相关。 FoxP3和CXCL12表达与鳞状 和腺瘤性病变密切相关。酶联免疫吸附试验和蛋白质印迹法支持了这些观察。在 中,我们证明了ThinPrep宫颈涂片中的脉动细胞 表达了CXCL12。这项研究强有力地将 CXCL12表达和FoxP3 + -细胞浸润与HPV感染和宫颈癌的发展密切相关。它支持在宫颈涂片和活组织检查中检测CXCL12 ,作为该疾病的附加生物标志物

著录项

  • 来源
    《American Journal of Pathology》 |2009年第4期|1525-1535|共11页
  • 作者单位

    From the Department of Histopathology and Cytology,Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom;

    and the Infectious Diseases Division and Dana-Farber Harvard Cancer Center,Massachusetts General Hospital, Boston, Massachusetts;

    and the Infectious Diseases Division and Dana-Farber Harvard Cancer Center,Massachusetts General Hospital, Boston, Massachusetts;

    and the Infectious Diseases Division and Dana-Farber Harvard Cancer Center,Massachusetts General Hospital, Boston, Massachusetts;

    From the Department of Histopathology and Cytology,Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom;

    From the Department of Histopathology and Cytology,Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom;

    From the Department of Histopathology and Cytology,Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom;

    From the Department of Histopathology and Cytology,Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom;

    From the Department of Histopathology and Cytology,Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom;

    From the Department of Histopathology and Cytology,Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom;

    From the Department of Histopathology and Cytology,Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom;

    and the Infectious Diseases Division and Dana-Farber Harvard Cancer Center,Massachusetts General Hospital, Boston, Massachusetts;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号